David Kirske, Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 11,767 shares at $2.86 ($34K) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Open-market sale of $34k XFOR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.